drugset / Trial / NCT03055403
First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase I first-in-human is designed to evaluate the safety, tolerability and pharmacokinetics of single ascending doses of M201-A administered by single continuous intravenous injection in Healthy Japanese subjects.
Timeline
- Start
- 2017-02-17
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | M201-A | Unknown | — | Intravenous |
Indications
No indication recorded.